Logo-bi
Original Research
Bahman Yousefi, Masoud Darabi*, Behzad Baradaran, Mahmoud Shekari Khaniani, Mohammad Rahbani, Maryam Darabi, Shabnam Fayezi, Amir Mehdizadeh, Negar Saliani, Maghsod Shaaker
Bioimpacts. 2012;2(3): 145-150. doi: 10.5681/bi.2012.019
PMCID: PMC3648933     PMID: 23678452     Scopus ID: 84876717030    
PDF
XML
Cited By:
Short Communication
Soheila Rezapour-Firouzi, Seyed Rafie Arefhosseini*, Mehdi Farhoudi, Mehrangiz Ebrahimi-Mamaghani, Mohammad-Reza Rashidi, Mohammad-Ali Torbati, Behzad Baradaran
Bioimpacts. 2013;3(1): 43-47. doi: 10.5681/bi.2013.001
PMCID: PMC3648912     PMID: 23678469     Scopus ID: 84879193741    
PDF
XML
Cited By:
Original Research
Jalil Pirayesh Islamian*, Mohsen Mohammadi, Behzad Baradaran, Alireza Farajollahi, Seyed Mahmoud Reza Aghamiri, Mohammad Asghari Jafarabadi, Haadi Karami, Amir Monfaredan, Dariuosh Shanehbandi
Bioimpacts. 2016;6(2): 93-98. doi: 10.15171/bi.2016.13
PMCID: PMC4981254     PMID: 27525226     Scopus ID: 84983516628    
Original Research
Keyvan Yousefi, Sanaz Hamedeyazdan, Darya Hodaei, Farzaneh Lotfipour, Behzad Baradaran, Mona Orangi, Fatemeh Fathiazad*
Bioimpacts. 2017;7(2): 75-82. doi: 10.15171/bi.2017.10
PMCID: PMC5524988     PMID: 28752071     Scopus ID: 85027462494    
Review
Leila Rostamizadeh ORCID, Ommoleila Molavi* ORCID, Mohsen Rashid, Fatemeh Ramazani, Behzad Baradaran, Afsaneh Lavasanaifar, Raymond Lai
BioImpacts. 2022;12(3): 261-290. doi: 10.34172/bi.2022.23896
PMCID: PMC9124882     PMID: 35677663     Scopus ID: 85132074584    
In this paper, we will review the application of the four most widely studied TLR agonists including agonists of TLR3, 4, 7, and 9 in cancer immunotherapy.
Original Article
Farzaneh Bilan ORCID, Mohammad Amini, Mohammad Amin Doustvandi, Maryam Tohidast, Amir Baghbanzadeh, Seyed Samad Hosseini ORCID, Ahad Mokhtarzadeh* ORCID, Behzad Baradaran*
Bioimpacts. 2024;14(2): 27764. doi: 10.34172/bi.2023.27764
PDF
XML
Cited By:
Original Article
Sheyda Jodeiry Zaer ORCID, Mahmoudreza Aghamaali*, Mohammad Amini, Mohammad Amin Doustvandi, Seyed Samad Hosseini ORCID, Behzad Baradaran, Souzan Najafi, Yalda Baghay Esfandyari, Ahad Mokhtarzadeh* ORCID
Bioimpacts. 2024;. doi: 10.34172/bi.2023.29913
PDF
XML
Cited By:
Original Article
Negin Farzamikia ORCID, Seyyedeh Mina Hejazian, Soroush Mostafavi, Behzad Baradaran, Sepideh Zununi Vahed* ORCID, Mohammadreza Ardalan* ORCID
Bioimpacts. 2024;. doi: 10.34172/bi.2023.29981
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge